<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="188" height="12" font="1">http://www.scbt.com/datasheet-17796-brg-1</text>
<text top="613" left="238" width="79" height="12" font="1">-g-7-antibody.html</text>
<text top="77" left="138" width="38" height="12" font="1">12/31/11</text>
<text top="340" left="95" width="151" height="12" font="1">mouse monoclonal IgG1; 200 µg/ml </text>
<text top="352" left="95" width="378" height="12" font="1">raised against amino acids 209-296 mapping near the N-terminus of Brg-1 of human origin </text>
<text top="364" left="95" width="411" height="12" font="1">recommended for detection of Brg-1 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA</text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="127" height="12" font="1">Brg-1 (G-7) Antibody: sc-17796</text>
<text top="214" left="339" width="110" height="12" font="1">BRG1 (EntrezGeneID 6597)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="484" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="27" height="12" font="1">H1104</text>
<text top="300" left="215" width="37" height="12" font="1">sc-17796</text>
<text top="520" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="141" width="109" height="12" font="2">Other Purification Method</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="412" left="95" width="418" height="12" font="1">The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the </text>
<text top="424" left="95" width="78" height="12" font="1">brahma protein of </text>
<text top="436" left="95" width="412" height="12" font="1">Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate </text>
<text top="448" left="95" width="66" height="12" font="1">transcription of </text>
<text top="460" left="95" width="437" height="12" font="1">certain genes by altering the chromatin structure around those genes. The encoded protein is part of the </text>
<text top="472" left="95" width="23" height="12" font="1">large </text>
<text top="484" left="95" width="446" height="12" font="1">ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of </text>
<text top="496" left="95" width="66" height="12" font="1">genes normally </text>
<text top="508" left="95" width="440" height="12" font="1">repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the </text>
<text top="521" left="95" width="111" height="12" font="1">tumorigenic protein CD44.</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="395" height="12" font="1">Comment: A band consistent with the expected size of Brg1/SMARCA4 (~185kD) is observed in </text>
<text top="55" left="125" width="427" height="12" font="1">immunoblots using sc-17796 against nuclear lysate from HeLaS3.  This band is immunoprecipitated by </text>
<text top="67" left="125" width="400" height="12" font="1">antibody sc-10757 from HeLaS3 nuclear lysate, along with another major band at ~150kD.  Mass </text>
<text top="79" left="125" width="385" height="12" font="1">spectrometry confirms that both bands contain Brg1 in high abundance (see validation #2).   </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="59" height="12" font="1">Methodology </text>
<text top="55" left="130" width="423" height="12" font="1">HeLaS3 whole cell lysates were immunoprecipitated using sc17796, and the IP fraction was loaded on </text>
<text top="67" left="130" width="146" height="12" font="1">a 10% polyacrylamide gel (NuPAGE</text>
<text top="66" left="276" width="235" height="14" font="1">ｨ Bis-Tris Gel) and separated with an invitrogen NuPAGE </text>
<text top="79" left="130" width="389" height="12" font="1">electrophoresis system. The gel was silver-stained, gel fragments corresponding to the bands </text>
<text top="91" left="130" width="245" height="12" font="1">indicated were excised and destained using the SilverSNAP</text>
<text top="90" left="375" width="161" height="14" font="1">ｨ Stain for Mass Spectrometry (Pierce). </text>
<text top="103" left="130" width="402" height="12" font="1">Then proteins were trysinized using the in-gel digestion method. The samples were subjected to </text>
<text top="115" left="130" width="407" height="12" font="1">nanoflow chromatography using the nanoAcquity UPLC system (Waters Inc.) prior to introduction </text>
<text top="127" left="130" width="409" height="12" font="1">into the mass spectrometer for further analysis. Mass spectrometry was performed on a hybrid ion </text>
<text top="139" left="130" width="406" height="12" font="1">trap LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific) in positive electrospray ionization </text>
<text top="152" left="130" width="410" height="12" font="1">(ESI) mode. The spectra was acquired in a data dependent fashion consisting of full mass spectrum </text>
<text top="164" left="130" width="421" height="12" font="1">scan (300–2000 m/z) followed by MS/MS scan of the 3 most abundant parent ions. For the full scan in </text>
<text top="176" left="130" width="416" height="12" font="1">the orbitrap the automatic gain control (AGC) was set to 16106 and the resolving power for 400 m/z </text>
<text top="188" left="130" width="383" height="12" font="1">of 30,000. The MS/MS scans were done using the ion trap part of the mass spectrometer at a </text>
<text top="200" left="130" width="414" height="12" font="1">normalized collision energy of 24 V. Dynamic exclusion time was set to 100 s to avoid loss of MS/MS </text>
<text top="212" left="130" width="406" height="12" font="1">spectral information due to repeated sampling of the most abundant peaks.  Sequence data from </text>
<text top="224" left="130" width="386" height="12" font="1">MS/MS spectra was processed using the SEQUEST database search algorithm (Thermo Fisher </text>
<text top="236" left="130" width="420" height="12" font="1">Scientific).  The resulting protein identifications were brought into the Scaffold visualization software </text>
<text top="248" left="130" width="400" height="12" font="1">(Proteome Software) where the information was further refined resulting in improved protein id </text>
<text top="260" left="130" width="401" height="12" font="1">conformation.  Scaffold search criteria were set at 98% probability and required at least 2 unique </text>
<text top="272" left="130" width="67" height="12" font="1">peptides per id. </text>
<text top="284" left="130" width="2" height="12" font="1"> </text>
<text top="296" left="130" width="44" height="12" font="1">Comment </text>
<text top="308" left="130" width="355" height="12" font="1">Mass spectrometry identifies Brg1/SMARCA4 as the major component of the material </text>
<text top="320" left="130" width="412" height="12" font="1">immunoprecipitated with antibody sc-17796 and excised from the bands indicated in the figure.  A </text>
<text top="332" left="130" width="419" height="12" font="1">more detailed presentation of this data has been published (Euskirchen et.al., (2011) PLoS Genetics, 7</text>
<text top="344" left="130" width="396" height="12" font="1">(3):1-20), where an analysis of all associated proteins in presented.  This work confirms previous </text>
<text top="356" left="130" width="408" height="12" font="1">observations that many components of the SWI/SNF complex are associated with Brg1/SMARCA4, </text>
<text top="368" left="130" width="413" height="12" font="1">including three additional members, BAF155/SMARCC1, BAF170/SMARCC2, and Ini1/SMARCB1 , for </text>
<text top="380" left="130" width="237" height="12" font="1">which ENCODE ChIP-seq datasets are currently available. </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="6" family="Times" color="#000000"/>
	<fontspec id="4" size="6" family="Times" color="#000000"/>
	<fontspec id="5" size="10" family="Times" color="#000000"/>
	<fontspec id="6" size="16" family="Times" color="#000000"/>
<text top="181" left="246" width="35" height="10" font="3"><b>Gel Cut</b></text>
<text top="181" left="422" width="35" height="10" font="3"><b>Protein</b></text>
<text top="181" left="600" width="152" height="10" font="3"><b>Accession # # unique peptides</b></text>
<text top="192" left="261" width="6" height="10" font="4">A</text>
<text top="192" left="374" width="132" height="10" font="4">SMARCA4 SMARCA4 isoform 2</text>
<text top="192" left="601" width="56" height="10" font="4">IPI00029822</text>
<text top="192" left="703" width="11" height="10" font="4">46</text>
<text top="203" left="261" width="6" height="10" font="4">A</text>
<text top="203" left="288" width="369" height="10" font="4">ARID1A Isoform 2 of AT-rich interactive domain-containing protein 1A IPI00642705</text>
<text top="203" left="706" width="5" height="10" font="4">9</text>
<text top="214" left="261" width="6" height="10" font="4">A</text>
<text top="214" left="284" width="530" height="10" font="4">SMARCC2 Isoform 2 of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2</text>
<text top="214" left="601" width="56" height="10" font="4">IPI00150057</text>
<text top="214" left="706" width="5" height="10" font="4">2</text>
<text top="257" left="261" width="6" height="10" font="4">B</text>
<text top="257" left="374" width="132" height="10" font="4">SMARCA4 SMARCA4 isoform 2</text>
<text top="257" left="601" width="56" height="10" font="4">IPI00029822</text>
<text top="257" left="703" width="11" height="10" font="4">22</text>
<text top="268" left="261" width="6" height="10" font="4">B</text>
<text top="268" left="284" width="530" height="10" font="4">SMARCC2 Isoform 2 of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2</text>
<text top="268" left="601" width="56" height="10" font="4">IPI00150057</text>
<text top="268" left="703" width="11" height="10" font="4">10</text>
<text top="279" left="261" width="6" height="10" font="4">B</text>
<text top="279" left="300" width="279" height="10" font="4">ZMIZ1 Isoform 1 of Zinc finger MIZ domain-containing protein 1</text>
<text top="279" left="601" width="56" height="10" font="4">IPI00176571</text>
<text top="279" left="706" width="5" height="10" font="4">3</text>
<text top="290" left="261" width="6" height="10" font="4">B</text>
<text top="290" left="284" width="474" height="10" font="4">SMARCC1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1</text>
<text top="290" left="601" width="56" height="10" font="4">IPI00234252</text>
<text top="290" left="706" width="5" height="10" font="4">2</text>
<text top="444" left="51" width="275" height="15" font="5">IP was performed with nuclear extract from HeLaS3 cells</text>
<text top="438" left="325" width="4" height="22" font="6"> </text>
</page>
</pdf2xml>
